Clinical advantages of gradually reducing radius versus multi-radius total knee arthroplasty: a noninferiority randomized trial.


Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
26 Jan 2023
Historique:
received: 27 10 2022
accepted: 18 01 2023
entrez: 26 1 2023
pubmed: 27 1 2023
medline: 31 1 2023
Statut: epublish

Résumé

The rationale for gradually reducing radius (GR) femoral component aims to prevent flexion instability by gradually change the center of femoral rotation, unlike a discrete change by the multi-radius (MR) which is more common for most of total knee arthroplasties (TKA). However, no strong evidence has been reported the clinical significance of the GR design. This patient-blinded, parallel, non-inferiority trial conducted between January 2018-December 2020. Patients with knee osteoarthritis consented for cruciate retaining TKA were randomly allocated to a GR or MR group. Primary outcome measures were knee functions at postoperative 6 and 12 months using the Knee injury and Osteoarthritis Outcome Score (KOOS). Secondary outcome measures were performance-based tests (30-s chair stand test, 40-m fast paced walk test, and 3-m timed up and go test), and knee motions. Sixty patients were enrolled and randomized; GR (n = 30) and MR (n = 30) group. The changes of KOOS at 6 and 12 months from baseline showed clinical meaningful for both GR and MR group. At 6 and 12 months postoperatively, there was no significant difference between both groups in all KOOS subscales. The length of stay was not different between GR and MR group (5.93 ± 1.44 vs 6.17 ± 1.86 days, p = 0.59). Patients on both groups presented similar performance-based tests. However, the improvement in degrees of knee motion for the GR group was significantly greater than the MR group (34.67 ± 12.52 vs 23.67 ± 12.59, p = 0.001). GR was noninferiority to MR for the functional outcomes and performances after TKA. The GR femoral component gave more knee motions than did the MR prostheses. Level I, therapeutic study.

Sections du résumé

BACKGROUND BACKGROUND
The rationale for gradually reducing radius (GR) femoral component aims to prevent flexion instability by gradually change the center of femoral rotation, unlike a discrete change by the multi-radius (MR) which is more common for most of total knee arthroplasties (TKA). However, no strong evidence has been reported the clinical significance of the GR design.
METHODS METHODS
This patient-blinded, parallel, non-inferiority trial conducted between January 2018-December 2020. Patients with knee osteoarthritis consented for cruciate retaining TKA were randomly allocated to a GR or MR group. Primary outcome measures were knee functions at postoperative 6 and 12 months using the Knee injury and Osteoarthritis Outcome Score (KOOS). Secondary outcome measures were performance-based tests (30-s chair stand test, 40-m fast paced walk test, and 3-m timed up and go test), and knee motions.
RESULTS RESULTS
Sixty patients were enrolled and randomized; GR (n = 30) and MR (n = 30) group. The changes of KOOS at 6 and 12 months from baseline showed clinical meaningful for both GR and MR group. At 6 and 12 months postoperatively, there was no significant difference between both groups in all KOOS subscales. The length of stay was not different between GR and MR group (5.93 ± 1.44 vs 6.17 ± 1.86 days, p = 0.59). Patients on both groups presented similar performance-based tests. However, the improvement in degrees of knee motion for the GR group was significantly greater than the MR group (34.67 ± 12.52 vs 23.67 ± 12.59, p = 0.001).
CONCLUSION CONCLUSIONS
GR was noninferiority to MR for the functional outcomes and performances after TKA. The GR femoral component gave more knee motions than did the MR prostheses.
LEVEL OF EVIDENCE METHODS
Level I, therapeutic study.

Identifiants

pubmed: 36703203
doi: 10.1186/s12891-023-06177-4
pii: 10.1186/s12891-023-06177-4
pmc: PMC9878805
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

J Orthop Surg Res. 2019 May 16;14(1):139
pubmed: 31097037
J Bone Joint Surg Br. 2005 May;87(5):646-55
pubmed: 15855366
J Bone Joint Surg Br. 2007 Jul;89(7):893-900
pubmed: 17673581
Clin Orthop Relat Res. 2010 Jan;468(1):57-63
pubmed: 19844772
Age Ageing. 1997 Jan;26(1):15-9
pubmed: 9143432
World J Orthop. 2018 Mar 18;9(3):41-49
pubmed: 29564213
J Orthop Sci. 2022 May;27(3):665-671
pubmed: 33933328
Phys Ther. 2000 Sep;80(9):896-903
pubmed: 10960937
J Arthroplasty. 2016 Mar;31(3):646-54
pubmed: 26614746
J Biomech. 2013 Apr 26;46(7):1351-7
pubmed: 23499227
EFORT Open Rev. 2019 Aug 7;4(8):519-524
pubmed: 31538002
J Bone Joint Surg Am. 1971 Jul;53(5):945-62
pubmed: 5109122
J Arthroplasty. 2017 Feb;32(2):431-436
pubmed: 27600300
J Arthroplasty. 2020 Nov;35(11):3150-3155
pubmed: 32636110
Res Q Exerc Sport. 1999 Jun;70(2):113-9
pubmed: 10380242
Int Orthop. 2014 Oct;38(10):2079-86
pubmed: 24859940
Knee Surg Sports Traumatol Arthrosc. 2018 Jun;26(6):1645-1655
pubmed: 28656456
J Bone Joint Surg Am. 1971 Oct;53(7):1257-70
pubmed: 5170981
Ann Med Surg (Lond). 2017 Mar 29;17:33-37
pubmed: 28392915
J Orthop Surg Res. 2018 Mar 15;13(1):54
pubmed: 29544516
J Knee Surg. 2022 Jan;35(2):204-214
pubmed: 32659818

Auteurs

Sakkadech Limmahakhun (S)

Department of Orthopedic Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. sakka_lim@hotmail.com.

Anuchit Chaiamporn (A)

Department of Orthopedic Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Kasisin Klunklin (K)

Department of Orthopedic Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Warakorn Jingjit (W)

Department of Orthopedic Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH